Literature DB >> 7053897

Sequelae of the initial attack of acute rheumatic fever in children from north India. A prospective 5-year follow-up study.

S K Sanyal, A M Berry, S Duggal, V Hooja, S Ghosh.   

Abstract

We determined the outcome of acute rheumatic fever in 85 children from North India who had received regular antistreptococcal prophylaxis after their first attack. By the end of the 5-year follow-up, 33 patients had rheumatic heart disease. Mitral insufficiency, the most common valvular lesion, appeared in 91% of the patients, whereas mitral stenosis developed in only 18%. Initial carditis, congestive heart failure, cardiomegaly or moderate-to-severe mitral insufficiency significantly increased the risk of rheumatic heart disease (p less than 0.001). The recurrence rate of acute rheumatic fever in children who received continuous prophylaxis was 0.006 per patient-year. Most recurrence (92%) mimicked the first attack and produced further cardiac damage in five patients with carditis and in one patient with chorea. Cardiac status during the first attack of rheumatic fever and the continuity of prophylaxis were the major determinants of outcome. Statistical comparisons disclosed that with continuous prophylaxis, the prevalence rate, evolution and clinical spectrum of the sequelae of acute rheumatic fever in children from India do not differ significantly from those in the West.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7053897     DOI: 10.1161/01.cir.65.2.375

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  18 in total

Review 1.  Prevention and treatment of rheumatic heart disease in the developing world.

Authors:  Andrew C Steer; Jonathan R Carapetis
Journal:  Nat Rev Cardiol       Date:  2009-09-15       Impact factor: 32.419

2.  Reversibility of mitral regurgitation following rheumatic fever: clinical profile and echocardiographic evaluation.

Authors:  A S Kassem; T M el-Walili; S R Zaher; M Ayman
Journal:  Indian J Pediatr       Date:  1995 Nov-Dec       Impact factor: 1.967

3.  Secondary prophylaxis is important for the prevention of recurrent rheumatic fever in the Pacific.

Authors:  Andrew C Steer; Samantha Colquhoun; Joseph Kado; Jonathan R Carapetis
Journal:  Pediatr Cardiol       Date:  2011-08       Impact factor: 1.655

4.  Clinical Evaluation Versus Echocardiography in the Assessment of Rheumatic Heart Disease.

Authors:  Ashwin Reddy; S K Jatana; Mng Nair
Journal:  Med J Armed Forces India       Date:  2011-07-21

5.  Echo-based screening of rheumatic heart disease in children: a cost-effectiveness Markov model.

Authors:  Justin P Zachariah; Mihail Samnaliev
Journal:  J Med Econ       Date:  2015-02-09       Impact factor: 2.448

6.  Evaluation of the American Heart Association 2015 revised Jones criteria versus existing guidelines.

Authors:  Dinesh Kumar; Euden Bhutia; Pradeep Kumar; Binoy Shankar; Atul Juneja; Sudha Chandelia
Journal:  Heart Asia       Date:  2016-04-05

Review 7.  Infective endocarditis during infancy and childhood: current status.

Authors:  S K Sanyal; M A Saleh; A Abu-Melha
Journal:  Indian J Pediatr       Date:  1988 Jan-Feb       Impact factor: 1.967

Review 8.  Is there a need to modify the "revised" Jones diagnostic criteria of acute rheumatic fever?

Authors:  S K Sanyal; A Abu-Melha
Journal:  Indian J Pediatr       Date:  1988 Jan-Feb       Impact factor: 1.967

Review 9.  Screening for rheumatic heart disease: current approaches and controversies.

Authors:  Kathryn Roberts; Samantha Colquhoun; Andrew Steer; Bo Reményi; Jonathan Carapetis
Journal:  Nat Rev Cardiol       Date:  2012-11-13       Impact factor: 32.419

10.  Use of Doppler echocardiography to support the decision to discontinue secondary prophylaxis for patients with rheumatic fever and normal cardiac auscultation.

Authors:  Fátima Derlene da Rocha Araújo; Eugênio Marcos de Andrade Goulart; Zilda Maria Alves Meira
Journal:  Pediatr Cardiol       Date:  2012-12-13       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.